查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829230

2025年全球注射給藥裝置市場報告

Injectable Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，注射給藥裝置市場規模強勁成長，從2024年的495.9億美元增加至2025年的543億美元，複合年成長率達9.5%。預測期內的成長可歸因於老年人口的快速成長、醫療機構數量的增加、醫療保健支出的增加、生技藥品的成長以及自我給藥意識的增強。

預計未來幾年注射給藥裝置市場將強勁成長，到 2029 年將達到 738.5 億美元，複合年成長率為 8.0%。預測期內的成長可歸因於慢性病盛行率的上升、注射藥物需求的增加、嚴重感染疾病的突然出現以及大量藥品和疫苗處於多個臨床試驗階段。預測期內的主要趨勢包括專注於開發基於微針的給藥系統、投資自行注射裝置的研發、專注於製造穿戴式設備、專注於製造無針注射系統、擴大產品線以包括預填充式注射器、探索設備的數位化改進、專注於製造創新設備以及專注於製造創新型自動注射器。

注射給藥裝置是專門設計用於透過注射將藥物直接注射到體內的醫療設備。此類裝置可用於多種給藥途徑，包括靜脈注射、皮下注射、皮內注射、腹腔注射和肌肉注射。

注射給藥裝置的主要類型包括傳統注射器、預填充式注射器、自動注射器和筆式注射器。預填充式注射器配有固定針頭，內含單劑量疫苗或其他藥物。這類裝置廣泛應用於各種醫療保健領域，包括自體免疫疾病、荷爾蒙失調、腫瘤學、罕見疾病、疼痛管理和呼吸治療。注射給藥裝置的終端用戶多種多樣，包括醫院和診所、家庭醫療保健機構、製藥和生物技術公司以及實驗室。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供注射給藥裝置的市場統計數據，包括全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的注射給藥裝置細分市場、市場趨勢和商業機會，為您提供在注射給藥裝置行業取得成功所需的數據。本注射給藥裝置市場研究報告提供了完整的行業觀點，並對當前和未來情況進行了深入分析。

未來五年8.0%的預測成長率，較我們先前對該市場的預測略有下降0.5%。下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致來自英國和台灣等主要地區的自動注射器彈簧和針頭安全護罩的供應鏈中斷，從而可能減少患者的自主用藥選擇，並增加慢性病管理成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響可能會更加廣泛。

由於人們對自動注射器的偏好日益成長，注射式給藥裝置市場正在蓬勃發展。這些醫療設備使患者能夠在家中自行給藥，包括無針注射器、自動注射器、筆式注射器和穿戴式注射器。一個顯著的例子是BD Physioject，這是一款由Becton, Dickinson and Company生產的一次性自動注射器，專為慢性疾病患者的自行注射藥物而設計。 Abbvie, Inc.、3M、Baxter、Gerresheimer AG和Pfizer Inc.等市場參與企業正積極參與自動注射器市場。自行注射的益處以及人們日益增強的自我給藥意識，正在推動此類裝置的需求不斷成長，從而推動注射式給藥裝置市場的發展。

慢性病盛行率的上升進一步推動了注射給藥裝置市場的成長。注射給藥裝置提供了一種便捷可靠的長期用藥方式，從而提高了患者的依從性並改善了健康狀況。美國國家生物技術資訊中心 (NCBI) 預測，全球慢性病患者人數將大幅增加，到 2050 年將達到 1.4266 億。慢性病盛行率的上升是注射給藥裝置市場的主要驅動力。

注射給藥設備市場的製造商正專注於自動注射器，這是一種全自動、可自訂且可重複使用的設備。自動注射器可讓患者控制注射速度，最大限度地減少疼痛和不適。 UniLife Corporation 可重複使用的自動注射器 LISA 提供藍牙低功耗連接、Wi-Fi 或 3G 連接以及注射前藥物加熱等功能。注射給藥技術的技術進步和新產品的推出預計將推動市場大幅成長。

注射給藥裝置市場的主要企業正致力於開發自動注射器平台，以提高患者依從性、增強可用性並實現更安全、更有效的給藥。自動注射器平台是一種旨在自動控制和給藥特定劑量的醫療設備。例如，2022 年 5 月，美國醫療保健公司 Jabil Healthcare Inc. 推出了 Qfinity 自動注射器平台，這是一種可重複使用的給藥裝置，用於皮下 (SC) 自行注射各種注射藥物。每個 Qfinity 自動注射器可注射超過 100 次，與一次性注射器相比，顯著減少了醫療廢棄物。這種耐用性促進了更永續的給藥方式。它在藥物容量和黏度方面具有靈活性，與 1 mL 和 2.25 mL預填充一次性盒相容，使其適用於多種藥物，包括大容量、高黏度注射。

注射給藥裝置市場的主要企業包括 Becton、Dickinson and Company、Baxter International、Gerresheimer AG、Catalent, Inc.、SkyePharma PLC、Antares Pharma、Pfizer Inc、GE Healthcare、Owen Mumford、Catalent Pharma Solutions、Philips、WestCoceutical Services, Inc.、 LLC、Pendant Biosciences、Siemens、H&T Presspart、B Braun、Cop​​ernicus、Ypsomed AG、3M Company、Aptar、Congenica Ltd.、Julphar、Nemera、Stryker、Roche、Nektar Therapeutics、Eli Lilly、Merck & Co. Inc. Inc. Inc. Inc. Inc. Ltd.、GlaxoSmithKline、MediPrint Ophthalmics、Medtronic、諾華、Pharmasyntez、拜耳、Mylan NV、Aptalis Pharma, Inc.、賽諾菲、諾和諾德、Bilim Pharmaceuticals、巴特爾醫療設備、Caplin Steriles Limited、雅培林、艾爾建、Bilim Pharmaceuticals、巴特爾醫療設備、Caplin Steriles Limited、雅培林、艾爾蓋、Bilim Pharmaceuticals、巴特爾醫療設備、Caplin Steriles Limited、雅培林、艾爾建、Terume、Trumn、Aaknillar. Corporation、Kedalion Therapeutics 和安進公司。

2024年，注射給藥裝置市場最大的地區是北美。西歐是全球注射給藥裝置市場的第二大地區。注射給藥裝置市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

注射藥物輸送裝置市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、加拿大、西班牙

注射給藥裝置市場涵蓋傳統注射器、無針注射器、自動注射器和筆式注射器的銷售。此市場的價值為出廠價，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球注射藥物輸送裝置：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球注射給藥裝置市場：成長率分析
  • 全球注射給藥裝置市場表現：規模與成長，2019-2024
  • 全球注射給藥裝置市場預測：規模與成長，2024-2029年，2034年
  • 全球注射給藥裝置：總目標市場（TAM）

第6章 市場細分

  • 全球注射給藥裝置市場類型、效能及預測（2019-2024、2024-2029、2034）
  • 注射器
  • 注射器
  • 泵浦
  • 全球注射給藥裝置市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 自體免疫疾病
  • 荷爾蒙失調
  • 腫瘤學
  • 罕見疾病
  • 疼痛管理
  • 呼吸治療
  • 其他
  • 全球注射給藥裝置市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 家庭醫療保健環境
  • 製藥和生物技術公司
  • 實驗室
  • 其他
  • 全球注射給藥裝置市場：注射器細分、類型、性能及預測（2019-2024、2024-2029、2034）
  • 傳統注射器
  • 預填充式注射器
  • 安全注射器
  • 全球注射給藥裝置市場：注射器細分、類型、性能及預測（2019-2024、2024-2029、2034）
  • 自動注射器
  • 筆式注射器
  • 無針注射器
  • 全球注射給藥裝置市場：幫浦細分、類型、性能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 胰島素幫浦
  • 攜帶式輸液泵
  • 植入式幫浦

第7章 區域和國家分析

  • 全球注射給藥裝置市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球注射給藥裝置市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 注射給藥裝置市場：競爭格局
  • 注射給藥裝置市場：公司簡介
    • Becton, Dickinson and Company
    • Baxter International
    • Gerresheimer AG
    • Catalent, Inc.
    • SkyePharma PLC

第31章：其他領先和創新企業

  • Antares Pharma
  • Pfizer Inc
  • GE Healthcare
  • Owen Mumford
  • Catalent Pharma Solutions
  • Philips
  • West Pharmaceutical Services, Inc.
  • Alkermes
  • Schott AG
  • UCB
  • AstraZeneca
  • Johnson & Johnson
  • NEARMEDIC PLUS LLC
  • Pendant Biosciences
  • Siemens

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年注射給藥裝置市場：提供新機會的國家
  • 2029年注射給藥裝置市場：細分市場帶來新機會
  • 2029年注射給藥裝置市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25717u

Injectable Drug Delivery Devices are medical devices specifically designed to deliver medications directly into the body via injections. These devices are utilized for multiple routes of drug administration, including intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular.

The primary types of injectable drug delivery devices include conventional injectables, pre-filled syringes, auto-injectors, and pen injectors. Pre-filled syringes come with a fixed needle and contain single-dose vaccines or other medications. These devices find applications in various medical areas such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. Injectable drug delivery devices are utilized by a range of end-users, including hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The injectable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market statistics, including injectable drug delivery devices industry global market size, regional shares, competitors with injectable drug delivery devices market share, detailed injectable drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the injectable drug delivery devices industry. This injectable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable drug delivery devices market size has grown strongly in recent years. It will grow from $49.59 billion in 2024 to $54.3 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rapid growth in the elderly population, growth in the number of healthcare facilities, increased healthcare expenditure, growth in the biologics, and increasing awareness of self-administration.

The injectable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $73.85 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, increasing demand for injectable drugs, sudden emergence of severe infections and large numbers of drugs and vaccines in several clinical trial stages. Major trends in the forecast period include focus on developing microneedle-based drug delivery systems, invest in the research and development of self-injectable devices, focus on manufacturing wearable devices, focus on the manufacturing of needle-free injection system, expanding its product line to prefilled syringes, consider improving the digital technology of their devices, focus on manufacturing innovative devices and focus on manufacturing innovative auto-injectors.

The forecast of 8.0% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for auto-injector springs and needle safety shields, sourced from key regions such as the UK and Taiwan, which could lead to reduced patient self-administration options and higher costs for chronic disease management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The injectable drug delivery devices market is experiencing growth driven by the increasing preference for self-injection devices. These medical devices enable patients to self-administer medication in a home setting and include needle-free, auto, pen, and wearable injectors. Notable examples include BD Physioject, a disposable auto-injector by Becton, Dickinson, and Company, designed for self-injection of drugs in chronic diseases. Companies such as Abbvie, Inc., 3M, Baxter, Gerresheimer AG, and Pfizer Inc. are actively participating in the self-injections market. The advantages of self-injectables and growing awareness of self-administration contribute to the rising demand for such devices, propelling the injectable drug delivery devices market.

The growth of the injectable drug delivery devices market is further fueled by the increasing prevalence of chronic diseases. Injectable drug delivery devices offer a convenient and reliable method for administering medications over extended periods, enhancing patient adherence and improving health outcomes. The National Center for Biotechnology Information (NCBI) projects a significant increase in the global population with chronic diseases, reaching 142.66 million by 2050. This escalating prevalence is a key driver for the injectable drug delivery devices market.

Manufacturers in the injectable drug delivery devices market are placing emphasis on auto-injectors, fully automated, customizable, and reusable devices. Auto-injectors provide patients with control over injection speed, minimizing pain or discomfort. Unilife Corporation's LISA, a reusable auto-injector, offers features such as Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming. The technological advancements and new product launches in injectable drug delivery technology are expected to drive significant market growth.

Major companies in the injectable drug delivery devices market are focusing on developing autoinjector platforms to improve patient compliance, enhance usability, and ensure safer and more effective medication administration. An autoinjector platform is a medical device designed for the automatic and controlled delivery of a specific medication dosage. For example, in May 2022, Jabil Healthcare Inc., a US-based healthcare company, introduced the Qfinity autoinjector platform, a reusable drug delivery device intended for subcutaneous (SC) self-administration of various injectables. The Qfinity autoinjector can manage over 100 injections per device, significantly reducing medical waste compared to single-use devices. This durability promotes a more sustainable approach to drug delivery. It can accommodate 1 mL and 2.25 mL pre-filled disposable cassettes, providing flexibility in drug volume and viscosity, making it suitable for a wide array of medications, including larger-volume and higher-viscosity injectables.

Major companies operating in the injectable drug delivery devices market include Becton, Dickinson and Company, Baxter International, Gerresheimer AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Syringes, Injectors And Pump
  • 2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
  • 3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
  • Subsegments:
  • 1) By Syringes: Conventional Syringes; Prefilled Syringes; Safety Syringes
  • 2) By Injectors: Autoinjectors; Pen Injectors; Needle-Free Injectors
  • 3) By Pumps: Insulin Pumps; Ambulatory Infusion Pumps; Implantable Pumps
  • Companies Mentioned: Becton, Dickinson and Company; Baxter International; Gerresheimer AG; Catalent, Inc.; SkyePharma PLC; Antares Pharma; Pfizer Inc; GE Healthcare; Owen Mumford; Catalent Pharma Solutions; Philips; West Pharmaceutical Services, Inc.; Alkermes; Schott AG; UCB; AstraZeneca; Johnson & Johnson; NEARMEDIC PLUS LLC; Pendant Biosciences; Siemens; H&T Presspart; B Braun; Copernicus; Ypsomed AG; 3M Company; Aptar; Congenica Ltd.; Julphar; Nemera; Stryker; Roche; Nektar Therapeutics; Eli Lilly; Merck & Co. Inc.; Sandoz; Sorrel Medical; Teleflex Medical; Gilero; Teva Pharmaceutical Industries Ltd.; GlaxoSmithKline; MediPrint Ophthalmics; Medtronic; Novartis; Pharmasyntez; Bayer; Mylan N.V; Aptalis Pharma, Inc.; Sanofi; Novo Nordisk; Bilim Pharmaceuticals; Battelle Medical Devices; Caplin Steriles Limited; Abbot; Allergan; Boehringer Ingelheim; Hovione Technology; Jiangsu Delfu Medical Device Co, Ltd.; Syqe Medical; Terumo Corporation; Kedalion Therapeutics; Amgen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Injectable Drug Delivery Devices Market Characteristics

3. Injectable Drug Delivery Devices Market Trends And Strategies

4. Injectable Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Injectable Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Injectable Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Injectable Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Injectable Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Injectable Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Injectable Drug Delivery Devices Total Addressable Market (TAM)

6. Injectable Drug Delivery Devices Market Segmentation

  • 6.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Syringes
  • Injectors
  • Pump
  • 6.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.3. Global Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Home Healthcare Settings
  • Pharmaceutical And Biotechnological Companies
  • Research Laboratories
  • Other End Users
  • 6.4. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Syringes
  • Prefilled Syringes
  • Safety Syringes
  • 6.5. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autoinjectors
  • Pen Injectors
  • Needle-Free Injectors
  • 6.6. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pumps
  • Ambulatory Infusion Pumps
  • Implantable Pumps

7. Injectable Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Injectable Drug Delivery Devices Market

  • 8.1. Asia-Pacific Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Injectable Drug Delivery Devices Market

  • 9.1. China Injectable Drug Delivery Devices Market Overview
  • 9.2. China Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Injectable Drug Delivery Devices Market

  • 10.1. India Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Injectable Drug Delivery Devices Market

  • 11.1. Japan Injectable Drug Delivery Devices Market Overview
  • 11.2. Japan Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Injectable Drug Delivery Devices Market

  • 12.1. Australia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Injectable Drug Delivery Devices Market

  • 13.1. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Injectable Drug Delivery Devices Market

  • 14.1. South Korea Injectable Drug Delivery Devices Market Overview
  • 14.2. South Korea Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Injectable Drug Delivery Devices Market

  • 15.1. Western Europe Injectable Drug Delivery Devices Market Overview
  • 15.2. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Injectable Drug Delivery Devices Market

  • 16.1. UK Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Injectable Drug Delivery Devices Market

  • 17.1. Germany Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Injectable Drug Delivery Devices Market

  • 18.1. France Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Injectable Drug Delivery Devices Market

  • 19.1. Italy Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Injectable Drug Delivery Devices Market

  • 20.1. Spain Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Injectable Drug Delivery Devices Market

  • 21.1. Eastern Europe Injectable Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Injectable Drug Delivery Devices Market

  • 22.1. Russia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Injectable Drug Delivery Devices Market

  • 23.1. North America Injectable Drug Delivery Devices Market Overview
  • 23.2. North America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Injectable Drug Delivery Devices Market

  • 24.1. USA Injectable Drug Delivery Devices Market Overview
  • 24.2. USA Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Injectable Drug Delivery Devices Market

  • 25.1. Canada Injectable Drug Delivery Devices Market Overview
  • 25.2. Canada Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Injectable Drug Delivery Devices Market

  • 26.1. South America Injectable Drug Delivery Devices Market Overview
  • 26.2. South America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Injectable Drug Delivery Devices Market

  • 27.1. Brazil Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Injectable Drug Delivery Devices Market

  • 28.1. Middle East Injectable Drug Delivery Devices Market Overview
  • 28.2. Middle East Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Injectable Drug Delivery Devices Market

  • 29.1. Africa Injectable Drug Delivery Devices Market Overview
  • 29.2. Africa Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Injectable Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Injectable Drug Delivery Devices Market Competitive Landscape
  • 30.2. Injectable Drug Delivery Devices Market Company Profiles
    • 30.2.1. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Baxter International Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Catalent, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SkyePharma PLC Overview, Products and Services, Strategy and Financial Analysis

31. Injectable Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Antares Pharma
  • 31.2. Pfizer Inc
  • 31.3. GE Healthcare
  • 31.4. Owen Mumford
  • 31.5. Catalent Pharma Solutions
  • 31.6. Philips
  • 31.7. West Pharmaceutical Services, Inc.
  • 31.8. Alkermes
  • 31.9. Schott AG
  • 31.10. UCB
  • 31.11. AstraZeneca
  • 31.12. Johnson & Johnson
  • 31.13. NEARMEDIC PLUS LLC
  • 31.14. Pendant Biosciences
  • 31.15. Siemens

32. Global Injectable Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market

34. Recent Developments In The Injectable Drug Delivery Devices Market

35. Injectable Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Injectable Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Injectable Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Injectable Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer